Irenic Capital urges Theravance to conduct review, add shareholder to board

Activist investor Irenic Capital Management is urging Theravance Biopharma Inc TBPH.O to initiate a review of strategic alternatives, including a full sale, and to add a shareholder to its board, according to a letter seen by Reuters.